[DPHARMA] QoQ Annualized Quarter Result on 30-Jun-2021 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
17-Aug-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
30-Jun-2021 [#2]
Profit Trend
QoQ- -6.31%
YoY- 16.66%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Revenue 743,764 639,175 658,308 643,786 665,816 569,902 581,088 17.90%
PBT 106,584 82,983 87,808 86,746 92,704 76,157 74,248 27.28%
Tax -25,420 -17,300 -21,185 -20,738 -22,248 -17,547 -17,692 27.35%
NP 81,164 65,683 66,622 66,008 70,456 58,610 56,556 27.25%
-
NP to SH 81,164 65,683 66,622 66,008 70,456 58,610 56,556 27.25%
-
Tax Rate 23.85% 20.85% 24.13% 23.91% 24.00% 23.04% 23.83% -
Total Cost 662,600 573,492 591,685 577,778 595,360 511,292 524,532 16.87%
-
Net Worth 621,987 621,564 612,147 614,350 635,424 642,484 584,565 4.22%
Dividend
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Div - 21,660 6,278 7,061 - 45,891 4,639 -
Div Payout % - 32.98% 9.42% 10.70% - 78.30% 8.20% -
Equity
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Net Worth 621,987 621,564 612,147 614,350 635,424 642,484 584,565 4.22%
NOSH 941,765 941,765 941,765 706,330 706,026 706,026 706,026 21.19%
Ratio Analysis
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
NP Margin 10.91% 10.28% 10.12% 10.25% 10.58% 10.28% 9.73% -
ROE 13.05% 10.57% 10.88% 10.74% 11.09% 9.12% 9.67% -
Per Share
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
RPS 80.12 67.87 69.90 91.17 94.30 80.72 83.50 -2.71%
EPS 8.76 6.98 7.08 9.34 9.96 8.46 8.21 4.42%
DPS 0.00 2.30 0.67 1.00 0.00 6.50 0.67 -
NAPS 0.67 0.66 0.65 0.87 0.90 0.91 0.84 -14.00%
Adjusted Per Share Value based on latest NOSH - 706,330
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
RPS 77.26 66.40 68.38 66.88 69.16 59.20 60.36 17.90%
EPS 8.43 6.82 6.92 6.86 7.32 6.09 5.88 27.17%
DPS 0.00 2.25 0.65 0.73 0.00 4.77 0.48 -
NAPS 0.6461 0.6457 0.6359 0.6382 0.6601 0.6674 0.6072 4.23%
Price Multiplier on Financial Quarter End Date
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Date 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 -
Price 1.49 1.68 1.81 3.03 2.75 3.38 3.16 -
P/RPS 1.86 2.48 2.59 3.32 2.92 4.19 3.78 -37.69%
P/EPS 17.04 24.09 25.59 32.41 27.56 40.72 38.88 -42.33%
EY 5.87 4.15 3.91 3.09 3.63 2.46 2.57 73.52%
DY 0.00 1.37 0.37 0.33 0.00 1.92 0.21 -
P/NAPS 2.22 2.55 2.78 3.48 3.06 3.71 3.76 -29.64%
Price Multiplier on Announcement Date
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Date 17/05/22 15/02/22 18/11/21 17/08/21 03/05/21 22/02/21 12/11/20 -
Price 1.51 1.60 1.62 2.49 2.93 3.42 4.04 -
P/RPS 1.88 2.36 2.32 2.73 3.11 4.24 4.84 -46.79%
P/EPS 17.27 22.94 22.90 26.64 29.36 41.20 49.71 -50.61%
EY 5.79 4.36 4.37 3.75 3.41 2.43 2.01 102.58%
DY 0.00 1.44 0.41 0.40 0.00 1.90 0.17 -
P/NAPS 2.25 2.42 2.49 2.86 3.26 3.76 4.81 -39.76%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment